Sort
21,281 grants matching “influenza”
Flipped Germinal Centers
$740,268Duane R. Wesemann · Brigham And Women'S Hospital · R01 · FY2023 · AI
Flipped Germinal Centers
$740,268Duane R. Wesemann · Brigham And Women'S Hospital · R01 · FY2024 · AI
System Immunogenetics of SARS-CoV Infection
$739,947Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI
Systems Pathogenomics of Severe Acute Respiratory Virus Infection
$739,767Ralph S Baric · Oregon Health & Science University · U54 · FY2010 · AI
Loss of Endothelial S1PR1 Drives Post-Influenza Pulmonary Fibrosis
$739,758Rachel S Knipe · Massachusetts General Hospital · R01 · FY2023 · HL
Broad spectrum inhibitors of paramyxovirus envelope proteins
$739,596Anne Moscona · Columbia University Health Sciences · R01 · FY2025 · AI
Systems biological analyses of innate responses to vaccination
$739,512Bali Pulendran · Emory University · U19 · FY2011 · AI
Pulmonary pathophysiology sub-phenotypes of pneumonia
$739,302Joseph P Mizgerd · Boston University Medical Campus · R01 · FY2025 · AI
Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients
$739,186Guang-Shing Cheng · Fred Hutchinson Cancer Center · R01 · FY2024 · HL
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants
$739,088Martha A. Alexander-Miller · Wake Forest University Health Sciences · R01 · FY2021 · AI
Immune response to COVID-19 vaccine in HIV infected men and women
$739,018Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Predictive Modeling of Estradiol Effects and Sex Differences on Immunopathology during Influenza Infection
$739,013Jason Edward Shoemaker · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients
$738,858Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2019 · AI
Development of an RSV vaccine for the elderly
$738,847Trudy G. Morrison · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI
Adenovirus Protease Regulation and Antiviral Development
$738,742Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2004 · AI
RFA-IP-22-004, Modeling toolkit to evaluate multifaceted control strategies for seasonal and pandemic influenza
$738,731Lauren Ancel Meyers · University Of Texas At Austin · U01 · FY2023 · IP
Modeling toolkit to evaluate multifaceted control strategies for seasonal and pandemic influenza
$738,730Lauren Ancel Meyers · University Of Texas At Austin · U01 · FY2022 · IP
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS: CLINICAL CORE
$738,396Chip Walter · Duke University · N01 · FY2021 · AI
New Therapies to Restore Vascular Integrity During Sepsis
$738,388Shannon J Odelberg · University Of Utah · R01 · FY2019 · HL
New Therapies to Restore Vascular Integrity During Sepsis
$738,388Shannon J Odelberg · University Of Utah · R01 · FY2020 · HL
B-cell repertoire analysis in influenza vaccination and infection
$737,906Hua-Xin Liao · Boston Children'S Hospital · P01 · FY2011 · AI
Role of alterations in the ATII cell lipidome in influenza pathogenesis
$737,880Ian Christopher Davis · Ohio State University · R01 · FY2019 · HL
Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases
$737,737Mary Bruce · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2015 · AI
SenSE:Wearable hybrid biochemical and biophysical sensing systems integrated with robust artificial intelligence for monitoring COVID-19 patients
$737,504Yi Zhang · University Of Missouri-Columbia · · FY2020 · ENG
Development of a novel quadrivalent seasonal influenza vaccine using E.coli production technology
$737,500Shengqiang Li · Sciogen, Llc · R44 · FY2016 · AI